Status:
COMPLETED
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Conditions:
Radiotherapy; Complications
Cardiotoxicity
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate and compare the changes by two modalities: Imaging by Strain by Speckle Tracking and Magnetic Resonance versus soluble markers of cardiac dysfunction as early ...
Eligibility Criteria
Inclusion
- ≥18 year-old patients
- With histologically confirmed thoracic cancer (breast, esophagus or lung)
- Recommendation of thoracic radiotherapy (RT) with curative intent
- With or without chemotherapy
- All patients must be able to read and understand Spanish
- All patients must sign informed consent form.
Exclusion
- Patients with no medical records,
- Pregnant
- Previously diagnosed with severe left ventricular dysfunction or a cardiac insufficiency
- Patients with metastatic disease and indication of palliative RT
- Patients with significant comorbidities associated to a \<5 year life expectancy.
- Patients previously treated with thoracic RT
Key Trial Info
Start Date :
January 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04896242
Start Date
January 9 2020
End Date
April 1 2024
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pontificia Universidad Catolica de Chile
Santiago, Santiago Metropolitan, Chile